Vitalia Home Acquisition & Valuation

Vitalia Home was acquired by StepStone Real Estate for $778M in October 2025, a 3.7x multiple on $210M of revenue.

Vitalia Home acquisition price

$778M

Acquired by StepStone Real Estate · Oct 2025

Vitalia Home revenue at acquisition

$210M

Last twelve months · Oct 2025

Vitalia Home revenue multiple at acquisition

3.7x

EV/Revenue · Oct 2025

Vitalia Home EBITDA multiple at acquisition

15.4x

EV/EBITDA · Oct 2025

Vitalia Home Overview

About Vitalia Home

Vitalia Home is Spain's second-largest care home owner-operator, providing residential and day care services for older adults across centers in regions including Andalusia, Aragon, and Catalonia. Its 'homes for living' model emphasizes onsite rehabilitation, 24-hour medical support, and restraint-free care, alongside long-term, medium-term, and palliative care services for residents with a range of needs.


Founded

1992

HQ

SpainSpain

Status

Acquired

Customer focus

B2C

Revenue model

Services

Revenue

$210M (Oct 2025)

Valuation

$1.7B (Oct 2025)

Vitalia Home Acquisition

Vitalia Home was acquired by StepStone Real Estate for $778M on 16 October 2025.

The acquisition price implies a 3.7x revenue and 15.4x EBITDA multiple on $210M of revenue.

Vitalia Home acquisition details
AcquirerDateTypePriceEV/RevenueEV/EBITDA
  • StepStone Real Estate
16 Oct 2025Strategic M&A$778M3.7x15.4x

Vitalia Home Valuation

Vitalia Home is currently valued at $1.7B, based on its secondary sale in October 2025.

The $577M round was led by GREYKITE, with participation from CVC Capital Partners.

Vitalia Home valuation by funding round

Vitalia Home valuation by funding round
DateStageValuation
Oct 2025Secondary$1.7B

Vitalia Home Funding History

Vitalia Home has 1 recorded secondary share sale and no primary funding rounds.

Vitalia Home funding rounds

Vitalia Home funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Oct 2025SecondaryGREYKITE (lead); CVC Capital Partners$577M$1.7BVitalia Home is Spain's second-largest care home owner-operator, specializing in comprehensive care and management of social and healthcare services for older adults with a resident-centered 'homes for living' model featuring onsite rehabilitation, 24-hour medical support, and restraint-free care. On October 16, 2025, StepStone Real Estate and GREYKITE announced a recapitalization transaction valued at €1.5 billion, acquiring a majority interest from Vivaly Investments BV (portfolio company of CVC Fund VI and Portobello Capital Fund III), with over €500 million committed in growth capital. GREYKITE acts as the general partner leading day-to-day management, while Vivaly Investments, CVC (retaining ~10%), Portobello (fully divested), and Vitalia's founder/senior management (retaining ~10%) hold minority stakes. The deal closed in November 2025 after fulfilling conditions precedent. This marks the largest investment in StepStone Real Estate Partners V (closed April 2025 with over $5 billion commitments) and the eighth portfolio company for GREYKITE European Real Estate Fund I (launched March 2024), targeting thematic real estate in living sectors amid demographic-driven growth.

Who has invested in Vitalia Home?

2 investors have backed Vitalia Home across its funding rounds, including CVC Capital Partners and GREYKITE.

Lead investors include GREYKITE.


Vitalia Home Investors

Investors in Vitalia Home by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 2 Vitalia Home investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Vitalia Home Competitors

Vitalia Home competitors include listed companies like WELL Health, Saudi German Health and Gushengtang Holdings, and private ones like Luz Saude, Aster DM Healthcare and Radiant Life Care Private Ltd.

Public and private companies comparable to Vitalia Home
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Luz SaudePortugalLisbonPrivate-$333M$3.2B-
WELL HealthCanadaCanadaPublicly listed$1B$110M$779M1.3x
Aster DM HealthcareUAEDubaiPrivate--$770M-
Radiant Life Care Private LtdIndiaMumbaiPrivate$64M$11M$816M12.8x
Saudi German HealthSaudi ArabiaSaudi ArabiaPublicly listed$827M$204M$732M1.6x
Gushengtang HoldingsChinaChinaPublicly listed$484M$93M$730M-
Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
WELL Health$1B$110M1.4x1.3x12.7x10.1x
Saudi German Health$827M$204M1.7x1.6x6.8x8.3x
Gushengtang Holdings$484M$93M1.6x-8.3x-
Diagnósticos da América$2.2B$346M0.9x1.0x5.6x4.9x
Global Medical Response$5.7B$1.1B0.9x0.9x4.7x-
Oncology Institute$503M($43M)1.5x1.2x(17.4x)(21274.9x)
Infracore$29K-33943.9x---
Al-Maidan Dental Clinic$205M$37M2.4x-13.0x-

This data is available for Pro users. Sign up to see all Vitalia Home competitors and their valuation data.

Start Free Trial

Common questions about Vitalia Home

When was Vitalia Home founded?Vitalia Home was founded in 1992.
Where is Vitalia Home headquartered?Vitalia Home is headquartered in Spain.
Is Vitalia Home publicly listed?No, Vitalia Home was acquired by StepStone Real Estate in October 2025.
Who acquired Vitalia Home?Vitalia Home was acquired by StepStone Real Estate in October 2025.
How much was Vitalia Home acquired for?Vitalia Home was acquired for $778M in October 2025, a 3.7x revenue multiple.
What is Vitalia Home's valuation?Vitalia Home was last valued at $1.7B in its secondary sale in October 2025.
Who are Vitalia Home's investors?Vitalia Home's investors include GREYKITE and CVC Capital Partners.
Which companies are comparable to Vitalia Home?Companies comparable to Vitalia Home include Luz Saude, WELL Health, Aster DM Healthcare, Radiant Life Care Private Ltd, Saudi German Health and Gushengtang Holdings.

See companies similar to Vitalia Home

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial